Afatinib 30 mg

Afatinib 30 mg is a targeted therapy medication used to treat certain types of non-small cell lung cancer (NSCLC). It works by blocking the EGFR protein, which is involved in the growth and survival of cancer cells.

Uses:

• Treatment of advanced non-small cell lung cancer (NSCLC) in patients with EGFR mutations.
• Treatment of metastatic squamous cell carcinoma of the head and neck (SCCHN) in patients with EGFR mutations.

Important Considerations:

1. Prescription Required: Afatinib is a prescription medication and should only be used under the supervision of a healthcare professional.
2. Potential Side Effects: Common side effects may include diarrhea, rash, dry skin, eye problems, and changes in taste. If you experience severe side effects, contact your doctor immediately.
3. Drug Interactions: Afatinib may interact with other medications. Inform your doctor about all prescription and over-the-counter drugs you are taking.